Emerging bacterial, fungal, and viral respiratory infections in transplantation

Shawn Nishi, Vincent G. Valentine, Steve Duncan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Kidney, liver, heart, pancreas, lung, and small intestine transplantations are viable therapeutic options for patients with end-stage organ failure. Ongoing advancements of surgical techniques, immunosuppressive regimens, and perioperative management have resulted in improved survival of allograft recipients. Despite these refinements, infections still contribute to substantial morbidity and mortality, limiting long-term success rates of these procedures. This article discusses the emerging bacterial, fungal, and viral respiratory infections in transplantation.

Original languageEnglish (US)
Pages (from-to)541-555
Number of pages15
JournalInfectious Disease Clinics of North America
Volume24
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Virus Diseases
Respiratory Tract Infections
Transplantation
Immunosuppressive Agents
Small Intestine
Allografts
Pancreas
Morbidity
Kidney
Lung
Mortality
Liver
Infection
Therapeutics

Keywords

  • Emerging
  • Respiratory infections
  • Transplant

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Emerging bacterial, fungal, and viral respiratory infections in transplantation. / Nishi, Shawn; Valentine, Vincent G.; Duncan, Steve.

In: Infectious Disease Clinics of North America, Vol. 24, No. 3, 2010, p. 541-555.

Research output: Contribution to journalArticle

@article{daa4e165330f420d8029a207993eb270,
title = "Emerging bacterial, fungal, and viral respiratory infections in transplantation",
abstract = "Kidney, liver, heart, pancreas, lung, and small intestine transplantations are viable therapeutic options for patients with end-stage organ failure. Ongoing advancements of surgical techniques, immunosuppressive regimens, and perioperative management have resulted in improved survival of allograft recipients. Despite these refinements, infections still contribute to substantial morbidity and mortality, limiting long-term success rates of these procedures. This article discusses the emerging bacterial, fungal, and viral respiratory infections in transplantation.",
keywords = "Emerging, Respiratory infections, Transplant",
author = "Shawn Nishi and Valentine, {Vincent G.} and Steve Duncan",
year = "2010",
doi = "10.1016/j.idc.2010.04.005",
language = "English (US)",
volume = "24",
pages = "541--555",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Emerging bacterial, fungal, and viral respiratory infections in transplantation

AU - Nishi, Shawn

AU - Valentine, Vincent G.

AU - Duncan, Steve

PY - 2010

Y1 - 2010

N2 - Kidney, liver, heart, pancreas, lung, and small intestine transplantations are viable therapeutic options for patients with end-stage organ failure. Ongoing advancements of surgical techniques, immunosuppressive regimens, and perioperative management have resulted in improved survival of allograft recipients. Despite these refinements, infections still contribute to substantial morbidity and mortality, limiting long-term success rates of these procedures. This article discusses the emerging bacterial, fungal, and viral respiratory infections in transplantation.

AB - Kidney, liver, heart, pancreas, lung, and small intestine transplantations are viable therapeutic options for patients with end-stage organ failure. Ongoing advancements of surgical techniques, immunosuppressive regimens, and perioperative management have resulted in improved survival of allograft recipients. Despite these refinements, infections still contribute to substantial morbidity and mortality, limiting long-term success rates of these procedures. This article discusses the emerging bacterial, fungal, and viral respiratory infections in transplantation.

KW - Emerging

KW - Respiratory infections

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=77955250349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955250349&partnerID=8YFLogxK

U2 - 10.1016/j.idc.2010.04.005

DO - 10.1016/j.idc.2010.04.005

M3 - Article

VL - 24

SP - 541

EP - 555

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

SN - 0891-5520

IS - 3

ER -